Close
Back to MTCR Stock Lookup

(MTCR) – FDA

Nov 2, 2021 08:01 AM Metacrine (MTCR) Reports Topline Results for MET409 Phase 2a Combination Trial
Oct 21, 2021 04:01 PM Metacrine (MTCR) Announces Interim Results for MET642 Phase 2a Trial in Patients with NASH; Announces Strategic Re-Prioritization of Its Clinical Development Programs
Jun 2, 2021 08:06 AM
May 18, 2021 08:08 AM
Mar 9, 2021 06:36 AM
Jan 19, 2021 06:33 AM
Jan 5, 2021 06:33 AM
Dec 17, 2020 06:30 AM
Oct 1, 2020 04:03 PM

Back to MTCR Stock Lookup